Patents Assigned to LAVA
  • Patent number: 12110328
    Abstract: The invention relates to compounds, in particular polypeptides that specifically bind to the non-classical MHC protein CD1d and modulate CD1d-mediated biological functions. The invention in particular relates to such compounds and polypeptides comprising or consisting of at least one single domain antibody, and wherein at least one single domain antibody specifically binds to CD1d. Also provided is for methods and use employing such compounds, polypeptides and/or single-domain antibodies.
    Type: Grant
    Filed: January 30, 2023
    Date of Patent: October 8, 2024
    Assignee: LAVA THERAPEUTICS N.V.
    Inventors: Johannes Jelle Van Der Vliet, Tanja Denise De Gruijl, Hendrik Marinus Willem Verheul, Renée Cornelia Gerarda De Bruin, Roeland Lameris
  • Patent number: 12077586
    Abstract: The present invention relates to novel methods for the treatment of hematological malignancies. In particular, the invention relates to the treatment of hematological malignancies using antibodies comprising a first binding moiety that is able to bind human CD1d and a second binding moiety that is able to bind the human V?9V?2-TCR.
    Type: Grant
    Filed: September 19, 2019
    Date of Patent: September 3, 2024
    Assignee: LAVA THERAPEUTICS N.V.
    Inventors: Iris De Weerdt, Arnon Philip Kater, Paul Willem Henri Ida Parren, Tanja Denise De Gruijl, Johannes Jelle Van Der Vliet, Roeland Lameris
  • Patent number: 11591394
    Abstract: The invention relates to compounds, in particular polypeptides that specifically bind to the non-classical MHC protein CD1d and modulate CD1d-mediated biological functions. The invention in particular relates to such compounds and polypeptides comprising or consisting of at least one single domain antibody, and wherein at least one single domain antibody specifically binds to CD1d. Also provided is for methods and use employing such compounds, polypeptides and/or single-domain antibodies.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: February 28, 2023
    Assignee: LAVA THERAPEUTICS N.V.
    Inventors: Johannes Jelle Van Der Vliet, Tanja Denise De Gruijl, Hendrik Marinus Willem Verheul, Renée Cornelia Gerarda De Bruin, Roeland Lameris
  • Patent number: 11384145
    Abstract: The invention is in the field of medicine and relates to immunology, and relates in particular to human V?9V?2 T cell receptor binding immunoglobulin molecules. Human V?9V?2 T cell receptor binding immunoglobulin molecules are in particular for use in medical treatment and/or useful in assays with human V?9V?2 T cells, wherein human V?9V?2 T cells may be modulated.
    Type: Grant
    Filed: October 28, 2021
    Date of Patent: July 12, 2022
    Assignee: LAVA THERAPEUTICS N.V.
    Inventors: Johannes Jelle Van Der Vliet, Renée Cornelia Gerarda De Bruin, Tanja Denise De Gruijl, Hendrik Marinus Willem Verheul
  • Patent number: 10984764
    Abstract: A guitar includes fibers of lengths between 0.2 millimeters to 3 millimeters. The guitar further includes a guitar body, a headstock board, a soundboard, a fretboard, and a guitar bridge. Each of the guitar body, the headstock board, the soundboard, the fretboard, and the guitar bridge is a continuous and single structure. The disclosure also relates to a guitar and a method for manufacturing a guitar. The guitar is superior to the traditional acoustic guitars in terms of volume and mechanical performance, so that a service life of the guitar of the application can be increased by 2 to 3 times compared with traditional acoustic guitars and durable.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: April 20, 2021
    Assignee: GUANGZHOU LAVA MUSIC INFO TECH LTD.
    Inventors: Zi-Tian Lu, Rui Zhong
  • Patent number: 10662558
    Abstract: A method for producing a double jersey fabric on a double jersey, single jacquard circular knitting machine includes steps of knitting a front side of the fabric on a cylinder (C) and knitting the rear side of the fabric on a dial (D) of the machine, knitting a base yarn on a rear side of the fabric, except for connecting points where the base yarn is knitted on the front side of the fabric. The method additionally includes steps of inserting a pattern yarn before a start of a pattern unit, which is produced using the pattern yarn, knitting the pattern yarn on the front side of the fabric in the pattern unit and cutting off the pattern yarn after the pattern unit.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: May 26, 2020
    Assignee: Lava BVBA
    Inventor: Johan Vanwelden
  • Patent number: 10549485
    Abstract: There is described a packaging apparatus (1) for forming sealed packages (2) from a tube (3). The packaging apparatus (1) has an endless conveyor device (7) arranged in a conveyor zone (8), conveying carts (9) and operative units (10, 10?) moved by the plurality of conveying carts (9) along a path (P, Q). Each operative unit (10, 10?) moves between an operative configuration, in which the operative unit (10, 10?) manipulates the tube (3) and a rest configuration in which the operative unit (10, 10?) is detached from the tube (3). Each operative unit (10, 10?) has a half-shell (36) and one of a sealing element (37a) or a counter-sealing element (37b) and each operative unit (10, 10?) is carried by one respective conveying cart (9) and extends laterally away therefrom so that the conveyor zone (8) is laterally spaced apart from an operative zone (33) where the tube is manipulated.
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: February 4, 2020
    Assignee: TETRA LAVA HOLDINGS & FINANCE S.A.
    Inventors: Paolo Fontanazzi, Davide Borghi, Massimo Pradelli, Stefano Flore, Fabrizio Rimondi, Fabio Curbastro Ricci
  • Patent number: 10501541
    Abstract: The invention relates to compounds, in particular polypeptides that specifically bind to the non-classical MHC protein CD1d and modulate CD1d-mediated biological functions. The invention in particular relates to such compounds and polypeptides comprising or consisting of at least one single domain antibody, and wherein at least one single domain antibody specifically binds to CD1d. Also provided is for methods and use employing such compounds, polypeptides and/or single-domain antibodies.
    Type: Grant
    Filed: January 27, 2016
    Date of Patent: December 10, 2019
    Assignee: LAVA THERAPEUTICS B.V.
    Inventors: Johannes Jelle Van Der Vliet, Tanja Denise De Gruijl, Hendrik Marinus Willem Verheul, Renée Cornelia Gerarda De Bruin, Roeland Lameris
  • Patent number: 10501540
    Abstract: The invention is in the field of medicine and relates to immunology, and relates in particular to human V?9V?2 T cell receptor binding immunoglobulin molecules. Human V?9V?2 T cell receptor binding immunoglobulin molecules are in particular for use in medical treatment and/or useful in assays with human V?9V?2 T cells, wherein human V?9V?2 T cells may be modulated.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: December 10, 2019
    Assignee: LAVA Therapeutics B.V.
    Inventors: Johannes Jelle Van Der Vliet, Renée Cornelia Gerarda De Bruin, Tanja Denise De Gruijl, Hendrik Marinus Willem Verheul
  • Patent number: 10413082
    Abstract: Mattress covers are disclosed that enable a user to provide a distinct consumer marketing appearance to a mattress.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: September 17, 2019
    Assignee: A. Lava & Son Co.
    Inventors: Adam Lava, Jim McCarthy
  • Publication number: 20190263908
    Abstract: The invention is in the field of medicine and relates to immunology, and relates in particular to human V?9V?2 T cell receptor binding immunoglobulin molecules.
    Type: Application
    Filed: May 16, 2019
    Publication date: August 29, 2019
    Applicant: LAVA THERAPEUTICS B.V.
    Inventors: Johannes Jelle VAN DER VLIET, Renée Marinus Willem VERHEUL
  • Patent number: D905502
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: December 22, 2020
    Assignee: LANDIG + LAVA GmbH & Co. KG
    Inventor: Christian Landig
  • Patent number: D914434
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: March 30, 2021
    Assignee: LANDIG + LAVA GmbH & Co. KG
    Inventor: Christian Landig
  • Patent number: D919676
    Type: Grant
    Filed: September 3, 2019
    Date of Patent: May 18, 2021
    Assignee: LANDIG + LAVA GmbH & Co. KG
    Inventor: Christian Landig
  • Patent number: D1014611
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: February 13, 2024
    Assignee: GuangZhou LAVA MUSIC LLC.
    Inventors: Zi-Tian Lu, Wei Zhong
  • Patent number: D1014612
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: February 13, 2024
    Assignee: GuangZhou LAVA MUSIC LLC.
    Inventors: Zi-Tian Lu, Hao-Jun Zheng, Wei Zhong, Zhen-Hui Yu
  • Patent number: D1015416
    Type: Grant
    Filed: September 22, 2023
    Date of Patent: February 20, 2024
    Assignee: GuangZhou LAVA MUSIC LLC.
    Inventors: Zi-Tian Lu, Wei Zhong
  • Patent number: D1015417
    Type: Grant
    Filed: September 22, 2023
    Date of Patent: February 20, 2024
    Assignee: GuangZhou LAVA MUSIC LLC.
    Inventors: Zi-Tian Lu, Hao-Jun Zheng, Wei Zhong, Zhen-Hui Yu
  • Patent number: D1015418
    Type: Grant
    Filed: September 22, 2023
    Date of Patent: February 20, 2024
    Assignee: GuangZhou LAVA MUSIC LLC.
    Inventors: Zi-Tian Lu, Hao-Jun Zheng, Wei Zhong, Zhen-Hui Yu
  • Patent number: D1025728
    Type: Grant
    Filed: August 29, 2023
    Date of Patent: May 7, 2024
    Assignee: Yongkang Lava Star Industry and Trade Co., Ltd.
    Inventor: Gensong Chi